{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:40:14Z","timestamp":1790919614067,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1136\/ard.2004.031120","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T18:28:43Z","timestamp":1108146523000},"page":"ii30-ii36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":310,"special_numbering":"S2","title":["Psoriasis pathophysiology: current concepts of pathogenesis"],"prefix":"10.1016","volume":"64","author":[{"given":"J G","family":"Krueger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bowcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2004.031120_bib1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","article-title":"Psoriasis","volume":"361","author":"Lebwohl","year":"2003","journal-title":"Lancet"},{"key":"10.1136\/ard.2004.031120_bib2","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/mjd.2003.552","article-title":"Development and use of alefacept to treat psoriasis","volume":"49","author":"Krueger","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1136\/ard.2004.031120_bib3","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1001\/jama.290.23.3073","article-title":"Efalizumab Study Group. Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial","volume":"290","author":"Gordon","year":"2003","journal-title":"JAMA"},{"key":"10.1136\/ard.2004.031120_bib4","first-page":"264","article-title":"TNF-alpha and apoptosis: implications for the pathogenesis and treatment of psoriasis","volume":"1","author":"Victor","year":"2002","journal-title":"J Drugs Dermatol"},{"issue":"suppl II","key":"10.1136\/ard.2004.031120_bib5","doi-asserted-by":"crossref","first-page":"ii37","DOI":"10.1136\/ard.2004.030775","article-title":"Genetic epidemiology of psoriasis and psoriatic arthritis","volume":"64","author":"Rahman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.031120_bib6","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1093\/hmg\/ddh094","article-title":"The genetics of psoriasis, psoriatic arthritis and atopic dermatitis","volume":"13","author":"Bowcock","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1136\/ard.2004.031120_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1268","article-title":"A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis","volume":"35","author":"Helms","year":"2003","journal-title":"Nat Genet"},{"key":"10.1136\/ard.2004.031120_bib8","doi-asserted-by":"crossref","first-page":"F389","DOI":"10.1152\/ajprenal.2001.280.3.F389","article-title":"NHERF: targeting and trafficking membrane proteins","volume":"280","author":"Shenolikar","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1136\/ard.2004.031120_bib9","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1038\/sj.onc.1204774","article-title":"Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation","volume":"20","author":"Voltz","year":"2001","journal-title":"Oncogene"},{"key":"10.1136\/ard.2004.031120_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI200113518","article-title":"New functions for the NHERF family of proteins","volume":"108","author":"Weinman","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2004.031120_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4049\/jimmunol.168.2.541","article-title":"Cutting edge: negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly","volume":"168","author":"Itoh","year":"2002","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.031120_bib12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/geno.2002.6720","article-title":"Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map","volume":"79","author":"Hewett","year":"2002","journal-title":"Genomics"},{"key":"10.1136\/ard.2004.031120_bib13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ng1020","article-title":"A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans","volume":"32","author":"Prokunina","year":"2002","journal-title":"Nat Genet"},{"key":"10.1136\/ard.2004.031120_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ng1267","article-title":"An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis","volume":"35","author":"Tokuhiro","year":"2003","journal-title":"Nat Genet"},{"key":"10.1136\/ard.2004.031120_bib15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.8178173","article-title":"Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q","volume":"264","author":"Tomfohrde","year":"1994","journal-title":"Science"},{"key":"10.1136\/ard.2004.031120_bib16","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1002\/j.1460-2075.1996.tb00911.x","article-title":"Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002","volume":"15","author":"Brunn","year":"1996","journal-title":"EMBO J"},{"key":"10.1136\/ard.2004.031120_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1086\/345646","article-title":"A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting","volume":"72","author":"Karason","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard.2004.031120_bib18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s004399900182","article-title":"A genome-wide search for genes predisposing to familial psoriasis by using a stratification approach","volume":"105","author":"Samuelsson","year":"1999","journal-title":"Hum Genet"},{"key":"10.1136\/ard.2004.031120_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/378076","article-title":"CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis","volume":"73","author":"Rahman","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard.2004.031120_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1058","article-title":"Positional identification of Ncf1 as a gene that regulates arthritis severity in rats","volume":"33","author":"Olofsson","year":"2003","journal-title":"Nat Genet"},{"key":"10.1136\/ard.2004.031120_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature02119","article-title":"Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice","volume":"426","author":"Sakaguchi","year":"2003","journal-title":"Nature"},{"key":"10.1136\/ard.2004.031120_bib22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"key":"10.1136\/ard.2004.031120_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","article-title":"The immunologic basis for the treatment of psoriasis with new biologic agents","volume":"46","author":"Krueger","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1136\/ard.2004.031120_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/labinvest.3780242","article-title":"Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris","volume":"81","author":"Rottman","year":"2001","journal-title":"Lab Invest"},{"key":"10.1136\/ard.2004.031120_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/jaut.1999.0343","article-title":"CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry","volume":"14","author":"Ferenczi","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1136\/ard.2004.031120_bib26","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.4049\/jimmunol.165.7.4076","article-title":"Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells","volume":"165","author":"Bonish","year":"2000","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.031120_bib27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"key":"10.1136\/ard.2004.031120_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1136\/ard.2004.031120_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0190-9622(92)70203-R","article-title":"Epidermal dendritic cells in psoriasis possess a phenotype associated with antigen presentation: in situ expression of beta 2-integrins","volume":"27","author":"McGregor","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1136\/ard.2004.031120_bib30","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.4049\/jimmunol.151.11.6535","article-title":"Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets","volume":"151","author":"Nestle","year":"1993","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.031120_bib31","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00403-002-0334-y","article-title":"Comparison of the distribution and numbers of antigen-presenting cells among T-lymphocyte-mediated dermatoses: CD1a+, factor XIIIa+, and CD68+ cells in eczematous dermatitis, psoriasis, lichen planus and graft-versus-host disease","volume":"294","author":"Deguchi","year":"2002","journal-title":"Arch Dermatol Res"},{"key":"10.1136\/ard.2004.031120_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/1523-1747.ep12343596","article-title":"Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema","volume":"106","author":"Wollenberg","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1136\/ard.2004.031120_bib33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.192.5.681","article-title":"Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells","volume":"192","author":"Abrams","year":"2000","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2004.031120_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000051825","article-title":"In situ localization of CD83-positive dendritic cells in psoriatic lesions","volume":"204","author":"Koga","year":"2002","journal-title":"Dermatology"},{"key":"10.1136\/ard.2004.031120_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1172\/JCI117308","article-title":"Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines","volume":"94","author":"Nestle","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2004.031120_bib36","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1523-1747.2002.19515.x","article-title":"Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases","volume":"119","author":"Wollenberg","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1136\/ard.2004.031120_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1136\/ard.2004.031120_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physiolgenomics.00157.2002","article-title":"Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array","volume":"13","author":"Zhou","year":"2003","journal-title":"Physiol Genomics"},{"key":"10.1136\/ard.2004.031120_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2004.031120_bib40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/ard.2004.031120_bib41","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMoa030002","article-title":"A novel targeted T-cell modulator, efalizumab, for plaque psoriasis","volume":"349","author":"Lebwohl","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2004.031120_bib42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1067\/mjd.2003.307","article-title":"Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis","volume":"48","author":"Gottlieb","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1136\/ard.2004.031120_bib43","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept Psoriasis Study Group. Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"Leonardi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2004.031120_bib44","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1093\/nar\/25.21.4346","article-title":"Convergence of TNFalpha and IFN gamma signalling pathways through synergistic induction of IRF-1\/ISGF-2 is mediated by a composite GAS\/kappaB promoter element","volume":"25","author":"Pine","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.1136\/ard.2004.031120_bib45","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0264-410X(02)00535-2","article-title":"Generation of antigen-loaded dendritic cells in a serum-free medium using different cytokine combinations","volume":"21","author":"Buchler","year":"2003","journal-title":"Vaccine"},{"key":"10.1136\/ard.2004.031120_bib46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1523-1747.2001.01441.x","article-title":"Inflammatory skin disease in K14\/p40 transgenic mice: evidence for interleukin-12-like activities of p40","volume":"117","author":"Kopp","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1136\/ard.2004.031120_bib47","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.4049\/jimmunol.170.11.5438","article-title":"IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14\/p40 transgenic mice: evidence for enhanced cutaneous immunity","volume":"170","author":"Kopp","year":"2003","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.031120_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2002-12-3793","article-title":"Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis","volume":"102","author":"Xia","year":"2003","journal-title":"Blood"},{"key":"10.1136\/ard.2004.031120_bib49","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI200318986","article-title":"Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model","volume":"112","author":"Villadsen","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1136\/ard.2004.031120_bib50","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1084\/jem.20031482","article-title":"Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha","volume":"199","author":"Boyman","year":"2004","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2004.031120_bib51","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5858\/2003-127-178-IIRRIN","article-title":"Innate immune-related receptors in normal and psoriatic skin","volume":"127","author":"Curry","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1136\/ard.2004.031120_bib52","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/intimm\/12.2.151","article-title":"IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells","volume":"12","author":"Tominaga","year":"2000","journal-title":"Int Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724424084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724424084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2004.031120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T12:38:40Z","timestamp":1737549520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724424084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":52,"alternative-id":["S0003496724424084"],"URL":"https:\/\/doi.org\/10.1136\/ard.2004.031120","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis pathophysiology: current concepts of pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2004.031120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}